All of the following are the actions of β–blockers in CHF except:
Beta blockers may actually increase vasoconstriction by antagonizing the vasodilator action of β2 receptors.
Decrease in mortality associated with CHF
Antagonism of vasoconstriction due to sympathetic overactivity
Prevention of pathological remodelling of ventricular myocardium
Prevention of dangerous cardiac arrhythmias